Sales of antiretroviral agents for HIV will decline slightly over the next decade
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that major-market sales of antiretroviral agents for HIV will decline slightly over the next decade, from an estimated $13.3 billion in 2011 to $12.9 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Union Health Minister Ghulam Nabi Azad on Monday said that HIV infections have declined by 56% during the last decade from 2.7 lakh in 2000 to 1.2 lakh in 2009 in India.